Petter Björquist
Director/Board Member at PHASE HOLOGRAPHIC IMAGING PHI AB
Profile
Petter Björquist is currently the Chief Executive Officer at NovaHep AB, Chief Executive Officer at Verigraft AB, and Director at Phase Holographic Imaging AB, Stimuliver ApS, and ATMP Sweden.
Previously, he was the Vice President-Regenerative Medicine at Takara Bio Europe AB from 2002 to 2014.
Petter Björquist active positions
Companies | Position | Start |
---|---|---|
PHASE HOLOGRAPHIC IMAGING PHI AB | Director/Board Member | - |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Chief Executive Officer | - |
Verigraft
Verigraft BiotechnologyHealth Technology Verigraft engages in the development of personalized human tissues for transplantation. The company is headquartered in Gothenburg, Sweden. | Chief Executive Officer | 2014-01-31 |
Former positions of Petter Björquist
Companies | Position | End |
---|---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | 2013-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PHASE HOLOGRAPHIC IMAGING PHI AB | Health Technology |
Private companies | 3 |
---|---|
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Verigraft
Verigraft BiotechnologyHealth Technology Verigraft engages in the development of personalized human tissues for transplantation. The company is headquartered in Gothenburg, Sweden. | Health Technology |
- Stock Market
- Insiders
- Petter Björquist